Literature DB >> 2379391

Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group.

C L Sprung1, P N Peduzzi, C H Shatney, R M Schein, M F Wilson, J N Sheagren, L B Hinshaw.   

Abstract

Sepsis, an important cause of hospital mortality, continues to be a diagnostic and therapeutic challenge. To define more clearly the impact of encephalopathy on the course of sepsis, the various clinical signs of sepsis, blood culture results, and mortality rates were examined in relation to mental status in septic patients. Patients were classified as having an acutely altered mental status due to sepsis (AAMS), preexisting altered mental status (PAMS), or normal mental status (NMS). Twenty-three (307/1333) percent of the study patients had an acutely altered sensorium secondary to sepsis. Patients with AAMS had a higher mortality (49%) than patients with PAMS (41%) or patients with NMS (26%) (p less than .000001). Multivariate analysis disclosed that altered mental status, hypothermia, hypotension, thrombocytopenia, and the absence of shaking chills were independent predictors of increased mortality in the sepsis syndrome. Patients with Gram-negative bacteremia (28%) were as likely to have AAMS as patients with Gram-positive bacteremia (25%) or patients with negative blood cultures (23%). In summary, alterations in mental status are common in septic patients, and are associated with significantly higher mortality.

Entities:  

Mesh:

Year:  1990        PMID: 2379391     DOI: 10.1097/00003246-199008000-00001

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  103 in total

1.  Studying septic encephalopathy: what animal models can predict.

Authors:  Stefan Schraag
Journal:  Intensive Care Med       Date:  2003-05       Impact factor: 17.440

2.  Cell wall-mediated neuronal damage in early sepsis.

Authors:  Carlos J Orihuela; Sophie Fillon; S Hope Smith-Sielicki; Karim C El Kasmi; Geli Gao; Konstantinos Soulis; Avinash Patil; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Aversive memory in sepsis survivor rats.

Authors:  Clarissa M Comim; Larissa S Constantino; Fabricia Petronilho; João Quevedo; Felipe Dal-Pizzol
Journal:  J Neural Transm (Vienna)       Date:  2010-10-24       Impact factor: 3.575

4.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

Review 5.  Sepsis-associated delirium.

Authors:  Marion Ebersoldt; Tarek Sharshar; Djillali Annane
Journal:  Intensive Care Med       Date:  2007-04-05       Impact factor: 17.440

6.  Caecal ligation and puncture induced sepsis in the rat results in increased brain water content and perimicrovessel oedema.

Authors:  Heather F Brooks; Raymond F Moss; Nathan A Davies; Rajiv Jalan; D Ceri Davies
Journal:  Metab Brain Dis       Date:  2014-05-10       Impact factor: 3.584

7.  NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits.

Authors:  Marc Weberpals; Michael Hermes; S Hermann; Markus P Kummer; Dick Terwel; Alexander Semmler; Meike Berger; Michael Schäfers; Michael T Heneka
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 9.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

10.  Somatosensory evoked potentials as predictor of systemic inflammatory response syndrome in pigs?

Authors:  Henning Ohnesorge; Petra Bischoff; Jens Scholz; Enno Yekebas; Jochen Schulte am Esch
Journal:  Intensive Care Med       Date:  2003-02-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.